Dapagliflozin

Amber-G

Brand Name(s):Forxiga

Indication:Diabetes Mellitus Type 1 (in combination with insulin)

Rationale:

Considered:Sep-19

Review Date:Sep-24

Comments:
NICE TA597- includes evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a body mass index of at least 27 kg/m2 . https://www.nice.org.uk/guidance/ta597